Disclosures for "Effects of Solriamfetol on Neuropsychological Outcomes in Patients With Obstructive Sleep Apnea in the Real-world SURWEY Study  "
-
Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini Pharma. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia Pharmaceuticals. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JAZZ Pharmaceuticals. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Presisis.
-
Dr. Eglit has received personal compensation for serving as an employee of Axsome Therapeutics Inc. Dr. Eglit has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Developmental Neuropsychology: A Life-Span Developmental Journal. Dr. Eglit has stock in Axsome Therapeutics.
-
Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
-
Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmanovia. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.